This innovative new product provides advanced immunofluorescent staining of circulating tumour cells (CTCs) enriched from blood processed by Parsortix®
technology.
Latest report
Annual Report December 2023
Please click the links below to download our Annual and Interim Reports and Financial Statements
Open PDFFor any investor relations queries please contact
investor@angleplc.comFor any investor relations queries please contact
investor@angleplc.comThis innovative new product provides advanced immunofluorescent staining of circulating tumour cells (CTCs) enriched from blood processed by Parsortix®
technology.